Target type: biologicalprocess
The multiplication or reproduction of melanocytes, resulting in the expansion of a cell population. A melanocyte is a pigment cell derived from the neural crest. It contains melanin-filled pigment granules, which give a brown to black appearance. [CL:0000148, GOC:uh, PMID:22637532]
Melanocyte proliferation is a complex process involving a series of tightly regulated steps that govern the growth and division of melanocytes, the specialized pigment-producing cells found in the skin. This process is essential for maintaining skin pigmentation and protecting the body from harmful UV radiation.
Melanocyte proliferation is initiated by various stimuli, including UV radiation, hormones, and growth factors. Upon receiving these signals, melanocytes enter the cell cycle, a series of events leading to cell division. This process involves distinct phases: G1 (Gap 1), S (Synthesis), G2 (Gap 2), and M (Mitosis).
**G1 Phase:** This is the first growth phase, where the cell increases in size and synthesizes proteins necessary for DNA replication. Key proteins involved in this phase include cyclins and cyclin-dependent kinases (CDKs), which regulate cell cycle progression.
**S Phase:** During this phase, DNA replication occurs, creating two identical copies of the cell's genetic material. This is crucial for ensuring that each daughter cell receives a complete set of chromosomes.
**G2 Phase:** This is the second growth phase, where the cell continues to grow and synthesize proteins needed for mitosis. The cell also checks for errors in DNA replication and prepares for cell division.
**M Phase:** This phase involves nuclear division (karyokinesis) and cytoplasmic division (cytokinesis). During karyokinesis, the replicated chromosomes align along the cell equator and are separated into two identical sets, one for each daughter cell. Cytokinesis follows, dividing the cytoplasm and organelles to form two daughter cells.
**Regulation of Melanocyte Proliferation:**
Melanocyte proliferation is tightly regulated by a complex network of signaling pathways and transcription factors. Key signaling pathways involved include the MAPK (mitogen-activated protein kinase) pathway, the PI3K (phosphatidylinositol 3-kinase) pathway, and the Wnt pathway. These pathways are activated by various stimuli, including UV radiation, hormones, and growth factors.
Transcription factors, such as MITF (microphthalmia-associated transcription factor), play a crucial role in regulating the expression of genes involved in melanocyte development and proliferation. MITF is activated by signaling pathways and promotes the expression of genes involved in melanogenesis, cell cycle progression, and survival.
**Dysregulation of Melanocyte Proliferation:**
Dysregulation of melanocyte proliferation can lead to various skin disorders, including melanoma, a type of skin cancer. Mutations in genes involved in melanocyte proliferation, such as BRAF and KIT, can lead to uncontrolled cell growth and the development of melanoma.
**Therapeutic Targets for Melanocyte Proliferation:**
Understanding the molecular mechanisms underlying melanocyte proliferation has led to the development of new therapeutic targets for treating skin disorders, including melanoma. Targeting signaling pathways, transcription factors, and cell cycle regulators has shown promising results in preclinical studies and is being investigated in clinical trials.
In summary, melanocyte proliferation is a tightly regulated process involving cell cycle progression, signaling pathways, and transcription factors. Understanding the intricacies of this process is crucial for developing effective treatments for skin disorders, including melanoma.'
"
Protein | Definition | Taxonomy |
---|---|---|
Olfactory receptor 51E2 | An olfactory receptor 51E2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9H255] | Homo sapiens (human) |
Prolyl endopeptidase FAP | A prolyl endopeptidase FAP that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q12884] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-ketoglutaric acid | 2-oxoglutaric acid : An oxo dicarboxylic acid that consists of glutaric acid bearing an oxo substituent at position 2. It is an intermediate metabolite in Krebs cycle. | oxo dicarboxylic acid | fundamental metabolite |
glycine | alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid | EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical | |
hydroxypyruvic acid | 3-hydroxypyruvic acid : A 2-oxo monocarboxylic acid that is pyruvic acid in which one of the methyl hydrogens is substituted by a hydroxy group. It is an intermediate involved in the glycine and serine metabolism. hydroxypyruvic acid: RN given refers to parent cpd | 2-oxo monocarboxylic acid; 3-hydroxy monocarboxylic acid; primary alpha-hydroxy ketone | Escherichia coli metabolite; human metabolite |
palmitic acid | hexadecanoic acid : A straight-chain, sixteen-carbon, saturated long-chain fatty acid. Palmitic Acid: A common saturated fatty acid found in fats and waxes including olive oil, palm oil, and body lipids. | long-chain fatty acid; straight-chain saturated fatty acid | algal metabolite; Daphnia magna metabolite; EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor; plant metabolite |
urea | isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives. pseudourea: clinical use; structure | isourea; monocarboxylic acid amide; one-carbon compound | Daphnia magna metabolite; Escherichia coli metabolite; fertilizer; flour treatment agent; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite |
estriol | chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl. hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone | 16alpha-hydroxy steroid; 17beta-hydroxy steroid; 3-hydroxy steroid | estrogen; human metabolite; human xenobiotic metabolite; mouse metabolite |
epitestosterone | epitestosterone : An androstanoid that is the C-17 epimer of testosterone. Epitestosterone: The 17-alpha isomer of TESTOSTERONE, derived from PREGNENOLONE via the delta5-steroid pathway, and via 5-androstene-3-beta,17-alpha-diol. Epitestosterone acts as an antiandrogen in various target tissues. The ratio between testosterone/epitestosterone is used to monitor anabolic drug abuse. | 17alpha-hydroxy steroid; 3-oxo-Delta(4) steroid; androstanoid | androgen antagonist; human metabolite |
glycylglycine | dipeptide; dipeptide zwitterion | human metabolite | |
2-pyrrolidone | 2-pyrrolidone: RN given refers to parent cpd pyrrolidin-2-one : The simplest member of the class of pyrrolidin-2-ones, consisting of pyrrolidine in which the hydrogens at position 2 are replaced by an oxo group. The lactam arising by the formal intramolecular condensation of the amino and carboxy groups of gamma-aminobutyric acid (GABA). | pyrrolidin-2-ones | metabolite; polar solvent |
n-acetylglutamic acid | N-acetyl-L-glutamic acid : An N-acyl-L-amino acid that is L-glutamic acid in which one of the amine hydrogens is substituted by an acetyl group. N-acetylglutamic acid: RN given refers to (L)-isomer | N-acetyl-L-amino acid; N-acyl-L-glutamic acid | human metabolite; Saccharomyces cerevisiae metabolite |
tetrahydrocurcumin | tetrahydrocurcumin : A beta-diketone that is curcumin in which both of the double bonds have been reduced to single bonds. | beta-diketone; diarylheptanoid; polyphenol | metabolite |
n-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide | N-carbobenzoxyglycyl-prolyl-4-methylcoumarinyl amide: fluorogenic substrate for post-proline cleaving enzyme | ||
histidinol | L-histidinol : An amino alcohol that is propanol substituted by 1H-imidazol-4-yl group at position 3 and an amino group at position 2 (the 2S stereoisomer). | amino alcohol; imidazoles | EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor; Escherichia coli metabolite; human metabolite; Saccharomyces cerevisiae metabolite |
n-acetyl-n-formyl-5-methoxykynurenamine | N-acetyl-N-formyl-5-methoxykynurenamine: metabolite of melatonin; structure in first source | aromatic ketone | |
androstane-3,17-dione, (5alpha)-isomer | 5alpha-androstane-3,17-dione : The 5alpha-stereoisomer of androstane-3,17-dione. androstane-3,17-dione : An androstanoid that is androstane substituted by oxo groups at positions 3 and 17. androstane-3,17-dione: RN given refers to cpd without isomeric designation | 3-oxo-5alpha-steroid; androstane-3,17-dione | mouse metabolite |
19-hydroxy-4-androstene-3,17-dione | 17-oxo steroid; 19-hydroxy steroid; 3-oxo steroid; androstanoid | mouse metabolite | |
bradykinin | oligopeptide | human blood serum metabolite; vasodilator agent | |
sitagliptin | sitagliptin : A triazolopyrazine that exhibits hypoglycemic activity. | triazolopyrazine; trifluorobenzene | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; environmental contaminant; hypoglycemic agent; serine proteinase inhibitor; xenobiotic |
isotretinoin | isotretinoin : A retinoic acid that is all-trans-retinoic acid in which the double bond which is alpha,beta- to the carboxy group is isomerised to Z configuration. A synthetic retinoid, it is used for the treatment of severe cases of acne and other skin diseases. Isotretinoin: A topical dermatologic agent that is used in the treatment of ACNE VULGARIS and several other skin diseases. The drug has teratogenic and other adverse effects. | retinoic acid | antineoplastic agent; keratolytic drug; teratogenic agent |
vildagliptin | amino acid amide | ||
talabostat | talabostat: an antineoplastic agent; structure in first source | ||
linagliptin | linagliptin : A xanthine that is 7H-xanthine bearing (4-methylquinazolin-2-yl)methyl, methyl, but-2-yn-1-yl and 3-aminopiperidin-1-yl substituents at positions 1, 3, 7 and 8 respectively (the R-enantiomer). Used for treatment of type II diabetes. Linagliptin: A purine and quinazoline derivative that functions as an INCRETIN and DIPEPTIDYL-PEPTIDASE IV INHIBTOR. It is used as a HYPOGLYCEMIC AGENT in the treatment of TYPE II DIABETES MELLITUS. | aminopiperidine; quinazolines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
kyp 2047 | |||
bms 477118 | adamantanes; azabicycloalkane; monocarboxylic acid amide; nitrile; tertiary alcohol | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent | |
alogliptin | alogliptin : A piperidine that is 3-methyl-2,4-dioxo-3,4-dihydropyrimidine carrying additional 2-cyanobenzyl and 3-aminopiperidin-1-yl groups at positions 1 and 2 respectively (the R-enantiomer). Used in the form of its benzoate salt for treatment of type 2 diabetes. alogliptin: structure in first source | nitrile; piperidines; primary amino compound; pyrimidines | EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor; hypoglycemic agent |
gosogliptin | amino acid amide | ||
anagliptin | anagliptin: anagliptin hydrochloride salt is the active compound | amino acid amide | |
mk-3102 | pyrrolopyrazole | ||
8-hydroxyguanine | 7,8-dihydro-8-oxoguanine : An oxopurine that is guanine in which the hydrogen at position 8 is replaced by an oxo group and in which the nitrogens at positions 7 and 9 each bear a hydrogen. 7,8-dihydro-8-oxoguanine: was substituted for guanine at G(8), G(9), G(14), or G(15) in the human telomeric oligonucleotide 5'-d[AGGGTTAG(8)G(9)GTT AG(14)G(15)GTTAGGGTGT]-3' | oxopurine |